Canadian Viral Hepatitis Elimination Day

On Thursday, May 9, 2024, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada, CanHepC, CanHepB, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa.

#CanHepDay24  #HepCantWait

Thank you to our many members and allies who are helping amplify our call for the federal government, as well as each province and territory, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030.

FIVE FEDERAL ASKS

In 2016, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories, there are five key things the federal government can do now.

1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.
An updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan.

2. Testing: Update hepatitis C screening guidelines to be evidence-based, develop evidence-based screening guidelines for hepatitis B, and start offering free, voluntary STBBI testing and linkage to care for all immigrants and newcomers.
Canada’s hepatitis C screening guidelines recommend only screening people with certain risk factors, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis.

3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.
Hepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.
​
4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.
Hepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12, which have a vaccination rate of ~70%, missing the 90% WHO target.

5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.
In order to measure our progress in viral hepatitis elimination, we need reliable, fulsome data about how many people are affected.

Click on the image to save it